Aurobindo Pharma arm acquires non-oncology portfolio of Khandelwal Labs 0 01.01.2026 17:24 The Hindu The business generated a turnover of ₹113.5 crore in 2024-25 with an EBITDA of ₹28.9 crore. It has around 470 people strong field force and more than 1,600 stockists and other distribution related infrastructure. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
